Tim Grob

6PUBLICATIONS
19CO-AUTHORS
Medical mycologyGene and molecular therapyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 24, 2026
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

Emma L Boertjes, Tim Grob, Adil Al Hinai

|Jan 13, 2026
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

Emma L Boertjes, Tim Grob, Adil Al Hinai

|Oct 08, 2025
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia.

Dorien Pastoors, Marije Havermans, Roger Mulet-Lazaro

|Dec 18, 2024
Double mutant DNMT3A AML: a unique subtype experiencing increased DNA damage and poor prognosis.

Emma L Boertjes, Sanne Massaar, Annelieke Zeilemaker

|Oct 31, 2022
Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia.

Tim Grob, Mathijs A Sanders, Christian M Vonk

Pageof 1